Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Clinical Data, a biotechnology company, has announced that its Cogenics division, a provider of outsourced genomics services, has become the exclusive global provider of genotyping solutions for Astellas Pharma, a manufacturer of pharmaceuticals and related products.
Subscribe to our email newsletter
Cogenics’s offerings will include biorepository and extraction services in combination with whole genome association and targeted genotyping for Astellas’s clinical studies in the US, Europe and Asia.
Michael Lutz, global manager of Cogenics, said: “We are pleased to partner with Astellas, one of the world’s top pharmaceutical companies, to be their exclusive provider in offering our full spectrum of genotyping services. As life sciences’ research and pharmaceutical development truly becomes a global endeavor, we are well positioned to deliver comprehensive genotyping solutions to our customers worldwide.”